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BACKGROUND AND OBJECTIVES     
•   After acute myocardial infarction, vascular remodeling in the peri-
infarct area is essential to provide adequate perfusion, prevent 
additional myocyte loss, and aid in the  repair process. 
•   Fibroblast growth factor 2 (FGF2) is essential to the recovery of 
contractile function and limitation of infarct size after cardiac ischemia-
reperfusion  (IR) injury. 
•   The role of FGF2 in vascular remodeling after cardiac IR injury is 
currently unknown.   
 
METHODS                                                     
Animals:  Mice with a targeted ablation of the Fgf2 gene (Fgf2 KO) and wildtype littermate controls at 8-10 
weeks of age maintained on a C57BL6 background were generated as previously described1. 
Mouse Model of Closed-chest Cardiac Ischemia-Reperfusion Injury:  The mouse model of closed-chest 
cardiac ischemia-reperfusion injury was performed in the Mouse Cardiovascular Phenotyping Core at 
Washington University in St. Louis School of Medicine.  Mice were anesthetized with ketamine/xylazine 
(100mg/kg and 10 mg/kg, i.p.), prepped and ventilated through a tracheostomy. Mice were then subjected to 
a left mini-thoracotomy and the pericardium was dissected. An 8-0 polypropolene suture was passed under 
the proximal LAD artery, and the two ends of the  suture were threaded through a 0.5mm piece of PE-10 
tubing forming a loose snare around the LAD (Figure 1B). The suture was then exteriorized through each 
side of the chest wall and the chest wall was closed (Figure 1B). The mouse was removed from the 
respirator and allowed to recover for seven days.  After this recovery time, mice were re-anesthetized but 
not ventilated, and only the skin above the chest wall was reopened.  Mice were taped to an EKG board to 
observe ST segment changes during ischemia and reperfusion.  The suture ends were pulled apart gently 
until ST segment elevation appeared on the EKG showing LAD occlusion and was continued for 90 minutes 
of ischemia time (Figure 1A).  To induce reperfusion, the sutures were cut close to the chest wall releasing 
the tension, and reperfusion was confirmed with resolution of ST segment elevation.  The surgeon was 
blinded to mouse genotype for all interventions. 
 



















Figure 1:  Schematic (A) and  images (B) of in vivo, closed-chest, 
regional cardiac ischemia-reperfusion model.        
    
Histology:  Hearts were halted in diastole in potassium chloride saturated phosphate buffered saline, fixed 
in 10% formalin, and transferred to 70% ethanol the next day.  Hearts were paraffin-embedded and then 
sectioned transversely (5–10 μm).  To evaluate arteriole and venule remodeling, sections were labeled with 
Cy3-conjugated anti-smooth muscle acting antibody (1:500 dilution, Sigma) and counterstained with DAPI 
(Vector Laboratories).  To visualize capillary remodeling, sections were labeled with anti-CD31 antibody 
(1:20 dilution, Dianova) and Cy3 anti-rat IgG (1:5000 dilution, Sigma) and counterstained with DAPI. 
Myocyte autofluorescence was quenched with 0.1% Sudan Black/70% EtOH.  Fluorescence was visualized 
using a Zeiss ApoTome microscope, and digital images were captured and processed with AxioVision 
Release 4.8 software. Images were analyzed with NIH Image J software.  
Statistical Analysis:  All values are expressed as mean  standard error of the mean.  A Student’s t-test 
was utilized to determine statistical significance. Data with a p<0.05 were considered statistically significant. 
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Figure 2:  A) Representative images of smooth muscle actin (SMA) 
containing vessels in Fgf2 KO and wildtype hearts.  Ablation of the Fgf2 
gene has no baseline effect on vessel density (B) or vessel diameter 






















Figure 3:  A) Representative images of smooth muscle actin staining of 
time course of Fgf2 KO and wildtype hearts subjected to  IR injury.  B) 
Fgf2 KO hearts show decreased SMA positive vessels at both 3 days 
and 7 days of reperfusion compared to wildtype controls.  C)  Fgf2 KO 
hearts show increased vessel diameter at 7 days after IR injury.  n=3-8, 
*p<0.05 vs. wildtype, #p<0.05 vs. sham, +p<0.05 vs. 1 day time point.   
 








Figure 4:  A) Representative images of CD31 expression Fgf2 KO and 
wildtype hearts.  Ablation of the Fgf2 gene has no baseline effect on 






















Figure 5:  A) Representative images of time course of Fgf2 KO and 
wildtype hearts subjected to  IR injury.  B) Fgf2 KO hearts show 
decreased capillary density at both 3 days and 7 days of reperfusion 
compared to wildtype controls.  C)  There is no difference in capillary 
size among the treatment groups. n=3-8, *p<0.05 vs. wildtype, #p<0.05 
vs. sham, +p<0.05 vs. 1 day time point.  
 
 
SUMMARY         
• Ablation of the Fgf2 gene does not affect cardiac capillary or larger 
vessel number or size in the absence of injury. 
• Fgf2 knockout hearts show decreased numbers of smooth muscle 
actin containing vessels at both 3 days and 7 day after ischemia-
reperfusion injury as well as increased average vessel size at 7 days of 
reperfusion. 
• Fgf2 knockout hearts show decreased capillary density at both 3 
days and 7 days after ischemia-reperfusion injury, but no significant 





CONCLUSION        
This study demonstrates the necessity of endogenous fibroblast growth 
factor 2 in vascular remodeling in the peri-infarct zone in a clinically-
relevant animal model of acute myocardial infarction.  These findings  
suggest a potential role for modulation of FGF2 signaling as a 
therapeutic intervention to optimize vascular remodeling in the repair 
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